Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of TMEM74 mRNA | CTD | PMID:28960355 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TMEM74 mRNA | CTD | PMID:21570461 | 3,3',5,5'-tetrabromobisphenol A | increases expression | EXP | | 6480464 | tetrabromobisphenol A results in increased expression of TMEM74 mRNA | CTD | PMID:25172293 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of TMEM74 mRNA | CTD | PMID:30071829 | 5-fluorouracil | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of TMEM74 mRNA | CTD | PMID:16510598 | 6-propyl-2-thiouracil | increases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of TMEM74 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of TMEM74 mRNA | CTD | PMID:30047161 | aflatoxin B1 | affects expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of TMEM74 protein | CTD | PMID:20106945 | all-trans-retinoic acid | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of TMEM74 mRNA | CTD | PMID:21934132 | antirheumatic drug | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of TMEM74 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | increases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in increased expression of TMEM74 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | increases methylation | ISO | TMEM74 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of TMEM74 exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | TMEM74 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of TMEM74 5' UTR | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of TMEM74 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of TMEM74 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of TMEM74 mRNA | CTD | PMID:32528016 | bisphenol A | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM74 gene | CTD | PMID:31601247 | bisphenol A | affects expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of TMEM74 mRNA | CTD | PMID:30816183 | butanal | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of TMEM74 mRNA | CTD | PMID:26079696 | C60 fullerene | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of TMEM74 mRNA | CTD | PMID:19167457 | copper atom | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TMEM74 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TMEM74 mRNA | CTD | PMID:20971185 | Cuprizon | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of TMEM74 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TMEM74 mRNA | CTD | PMID:20106945 and PMID:27989131 | cypermethrin | increases expression | EXP | | 6480464 | cypermethrin results in increased expression of TMEM74 mRNA | CTD | PMID:29020013 | dorsomorphin | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | entinostat results in decreased expression of TMEM74 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | fulvestrant | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM74 gene | CTD | PMID:31601247 | ketamine | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of TMEM74 mRNA | CTD | PMID:20080153 | mercury dibromide | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of TMEM74 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | methotrexate | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of TMEM74 mRNA | CTD | PMID:24449571 | methylmercury chloride | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TMEM74 mRNA | CTD | PMID:28001369 | p-chloromercuribenzoic acid | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of TMEM74 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | panobinostat | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of TMEM74 mRNA | CTD | PMID:26272509 | paracetamol | increases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of TMEM74 mRNA | CTD | PMID:33387578 | paraquat | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of TMEM74 mRNA | CTD | PMID:32680482 | pentanal | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | pentanal results in increased expression of TMEM74 mRNA | CTD | PMID:26079696 | phenobarbital | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Phenobarbital results in decreased expression of TMEM74 mRNA | CTD | PMID:30047161 | phenylmercury acetate | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of TMEM74 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | propanal | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of TMEM74 mRNA | CTD | PMID:26079696 | SB 431542 | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sunitinib | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of TMEM74 mRNA | CTD | PMID:31533062 | trichloroethene | decreases expression | ISO | Tmem74 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of TMEM74 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of TMEM74 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | trichostatin A | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of TMEM74 mRNA | CTD | PMID:27188386 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of TMEM74 mRNA | CTD | PMID:35537566 | valproic acid | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TMEM74 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TMEM74 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TMEM74 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of TMEM74 mRNA | CTD | PMID:26272509 | vorinostat | multiple interactions | ISO | TMEM74 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | TMEM74 (Homo sapiens) | 6480464 | vorinostat results in increased expression of TMEM74 mRNA | CTD | PMID:27188386 | |